1
Total Mentions
1
Documents
0
Connected Entities
Name reference in documents
HOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102
ors of Chimerix (NASDAQ: CMRX, former Chairman) and Tioga. He was previously on the boards of Intarcia Therapuetics (now currently a Board observer), Sirna Therapeutics (NASDAQ: RNAI, acquired by Merck in 2006 for $1.1 billion), where he served as Chairman; Oriel Therapeutics (acquired by Novartis in 2010), where he
No connected entities